Pdc*line Pharma

Developer of therapeutic vaccines for the treatment of cancer

placeGrenoble, Auvergne Rhone Alpes, France calendar_todayFounded 2014 groups34 employees language pdc-line-pharma.com

Innovation

3 patent families (1 granted) — focus: Human necessities; filing pace steady. Cited 118 times.

YearFilings
20201
20211
20231
20242

Social engagement

Social engagement: 5.5K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Noshaq, UTC Investment, SRIW, Sambrinvest.

Investor typeCountShare
Venture capital321%
Private equity536%
Bank & private debt17%
Other / undisclosed536%
Coming soon